HOME >> MEDICINE >> NEWS
Surgical instruments may not be fair trade

The NHS may be buying medical equipment unethically and exploiting developing countries, it has been claimed in an article published on bmj.com today.

Unlike the campaigns for fair trade of goods like bananas and coffee, there have been no such campaigns for medical commodities, says Dr Mahmood Bhutta, a specialist registrar in otolaryngology (head and neck surgery) at Guy's and St Thomas' Hospital in London.

Dr Bhutta says that while NHS suppliers are encouraged to act in an ethical business manner, they do not and there are currently no checks or assessments made into the origins of surgical instruments used by the NHS.

"The trade in surgical instruments is open to unethical sourcing because many such instruments are manufactured in the developing world," writes Dr Bhutta.

The global trade in hand held stainless steel surgical instruments is worth around 352million ($650m, 507m) a year and many of these instruments are made by firms in towns in Europe and Asia. The two largest producers are Tuttlingen in Germany and Sialkot in Pakistan.

Companies in Sialkot use more traditional production methods with most instruments manufactured and finished by hand, so production is more labour intensive, employing 50,000 people (7,700 of whom are children aged from 7 and older) to supply a fifth of the world's surgical instruments.

Many firms in Sialkot sub-contact the initial production of these instruments to workers in small workshops or their own homes in an attempt to reduce overheads and minimise costs. These workers earn around 1 a day ($2, 1.50).

The firms sell to suppliers and retailers in the developed world who then sell on to companies in Germany which sell to the NHS and elsewhere in the world at a marked up price, says Dr Bhutta.

"The solution lies in purchasers insisting on fair and ethical trade when sourcing instruments," he adds.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ-British Medical Journal
27-Jul-2006


Page: 1

Related medicine news :

1. Ronald W. Busuttil receives American Surgical Associations highest honor
2. Surgical plugs in ears bone stops strange form of severe dizziness
3. Surgical critical care team at HUP earns Beacon Award for Critical Care Excellence
4. Call for data on reuse of surgical instruments to allay fears over vCJD transmission
5. ASTRO annual meeting again named a fastest growing tradeshow
6. Patent laws and US trade agreements are hindering access to HIV treatment
7. EUs free trade rules exacerbate alcohol-related harm
8. WHO must prepare health ministries for trade liberalisation
9. Book Asbestos and Fire explores risk trade-offs
10. Counting the human cost of international trade

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Surgical instruments may not fair trade

(Date:4/23/2014)... of endogenous neural precursor cells cannot alone compensate ... the perspective of neural plasticity, Dr. Yun Xiang ... observed the effects of functional electrical stimulation treatment ... of basic fibroblast growth factor and epidermal growth ... side. The researchers found that functional electrical stimulation ...
(Date:4/22/2014)... (Chicago) A recently FDA-approved device has been shown ... as much as 50 percent. When coupled with an ... Rush, the device facilitated the complete elimination of seizures ... in the decade-long clinical trials. , That,s good news ... in the U.S. living with epilepsy whose seizures can,t ...
(Date:4/22/2014)... all lung cancers are small cell lung cancers ... to chemotherapy. However, researchers at Virginia Commonwealth University ... the mechanisms leading to this resistance that may ... primarily by mediating B-cell lymphoma 2 (Bcl-2) family ... Depending on their function, this family of proteins ...
(Date:4/22/2014)... Hopkins scientists have found a way to block abnormal ... of atherosclerosis, the main cause of heart attacks and ... The condition develops when fat builds inside blood vessels ... greatly reducing their ability to feed oxygen-rich blood to ... series of experiments, described April 7 in the journal ...
(Date:4/22/2014)... massive health care spending, a new RAND study concludes ... incentivize pharmaceutical companies and device makers to develop products ... medical technologies and their use, a new study suggests ... medical devices get created in the first place. The ... as little loss of health as possible and to ...
Breaking Medicine News(10 mins):Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: